. Epithelial cell behavior is tightly regulated by the surrounding mE. This control is mediated through the coordinated actions of cell-cell adhesion, paracrine/autocrine growth factors and through adhesion to the extracellular matrix. Together, these mechanisms ensure that cells do not proliferate inappropriately or stray from their immediate mE niche. The process of oncogenic transformation and tumor progression entails the escape from these mechanisms, and the evolution ofthe tumor cell population towards phenotypes that allow them to become independent ofthe normal tissue mE. Activation ofthe underlying stromal fibroblasts, leading to the increased production of paracrine growth factors and pro-survival ECM is one way that developing tumors can achieve mE independence. The complexity of the host-tumor interaction in the carcinogenic process lends itself well to integrated experimental/mathematical based approaches, which are designed to handle multiple variables simultaneously. The current project will initially consider the mechanisms which control normal tissue homeostasis and subsequently homeostatic escape by using three different modeling approaches that examine the roles physical constraints, cell-mE interactions and evolutionary dynamics play in carcinogenesis. In the second part we will use novel in vitro organotypic cell culture models to test whether the presence of an activated stroma can provide the second

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA143970-05
Application #
8567244
Study Section
Special Emphasis Panel (ZCA1-SRLB-9)
Project Start
2013-09-01
Project End
2014-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
5
Fiscal Year
2013
Total Cost
$1,722,271
Indirect Cost
$619,907
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Adair, Jennifer E; Johnston, Sandra K; Mrugala, Maciej M et al. (2014) Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients. J Clin Invest 124:4082-92
Kam, Yoonseok; Das, Tuhin; Minton, Susan et al. (2014) Evolutionary strategy for systemic therapy of metastatic breast cancer: balancing response with suppression of resistance. Womens Health (Lond Engl) 10:423-30
Baldock, Anne L; Ahn, Sunyoung; Rockne, Russell et al. (2014) Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas. PLoS One 9:e99057
Gatenby, R A; Cunningham, J J; Brown, J S (2014) Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations. Nat Commun 5:5499
Lloyd, Mark C; Alfarouk, Khalid O; Verduzco, Daniel et al. (2014) Vascular measurements correlate with estrogen receptor status. BMC Cancer 14:279
McGillen, Jessica B; Gaffney, Eamonn A; Martin, Natasha K et al. (2014) A general reaction-diffusion model of acidity in cancer invasion. J Math Biol 68:1199-224
Kim, MunJu; Rejniak, Katarzyna A (2014) Mechanical aspects of microtubule bundling in taxane-treated circulating tumor cells. Biophys J 107:1236-46
Scott, Jacob G; Fletcher, Alexander G; Maini, Philip K et al. (2014) A filter-flow perspective of haematogenous metastasis offers a non-genetic paradigm for personalised cancer therapy. Eur J Cancer 50:3068-75
Bailey, Kate M; Wojtkowiak, Jonathan W; Cornnell, Heather H et al. (2014) Mechanisms of buffer therapy resistance. Neoplasia 16:354-64.e1-3
Baldock, Anne L; Yagle, Kevin; Born, Donald E et al. (2014) Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status. Neuro Oncol 16:779-86

Showing the most recent 10 out of 61 publications